Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia

被引:43
|
作者
Kawahata, Ichiro [1 ]
Fukunaga, Kohji [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 9808578, Japan
基金
日本学术振兴会;
关键词
Parkinson's disease; dopa-responsive dystonia; tyrosine hydroxylase; alpha-synuclein; fatty acid-binding protein 3; ubiquitination; proteasomal degradation; ubiquitin-proteasome system; PROTEIN PHOSPHATASE 2A; CHAPERONE-MEDIATED AUTOPHAGY; MUTANT ALPHA-SYNUCLEIN; COMPLEX I DEFICIENCY; N-TERMINAL REGION; SYNERGISTIC INTERACTIONS; AFFINITY PURIFICATION; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; MESSENGER-RNA;
D O I
10.3390/ijms21113779
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nigrostriatal dopaminergic systems govern physiological functions related to locomotion, and their dysfunction leads to movement disorders, such as Parkinson's disease and dopa-responsive dystonia (Segawa disease). Previous studies revealed that expression of the gene encoding nigrostriatal tyrosine hydroxylase (TH), a rate-limiting enzyme of dopamine biosynthesis, is reduced in Parkinson's disease and dopa-responsive dystonia; however, the mechanism of TH depletion in these disorders remains unclear. In this article, we review the molecular mechanism underlying the neurodegeneration process in dopamine-containing neurons and focus on the novel degradation pathway of TH through the ubiquitin-proteasome system to advance our understanding of the etiology of Parkinson's disease and dopa-responsive dystonia. We also introduce the relation of alpha-synuclein propagation with the loss of TH protein in Parkinson's disease as well as anticipate therapeutic targets and early diagnosis of these diseases.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia
    Furukawa, Y
    Kapatos, G
    Haycock, JW
    Worsley, J
    Wong, H
    Kish, SJ
    Nygaard, TG
    ANNALS OF NEUROLOGY, 2002, 51 (05) : 637 - 641
  • [2] Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency
    Furukawa, Y
    Kish, SJ
    Fahn, S
    ANNALS OF NEUROLOGY, 2004, 55 (01) : 147 - 148
  • [3] Neuropathology of dopa-responsive dystonia due to Tyrosine hydroxylase deficiency
    Schreglmann, S.
    Jaunmuktane, Z.
    Jung, H.
    Strand, C.
    Holton, J.
    Bhatia, K.
    MOVEMENT DISORDERS, 2018, 33 : S353 - S353
  • [4] A patient with dopa-responsive dystonia and juvenile Parkinson's disease
    Hjermind, LE
    Johannsen, LG
    Wevers, RA
    Blau, N
    Friberg, L
    Regeur, L
    MOVEMENT DISORDERS, 2004, 19 : S350 - S350
  • [5] The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease
    Liang, Yu
    Zhong, Guangshang
    Ren, Mingxin
    Sun, Tingting
    Li, Yangyang
    Ye, Ming
    Ma, Caiyun
    Guo, Yu
    Liu, Changqing
    NEUROMOLECULAR MEDICINE, 2023, 25 (04) : 471 - 488
  • [6] Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease
    Zhao, Yiting
    Lin, Man
    Zhai, Fengguang
    Chen, Jun
    Jin, Xiaofeng
    PHARMACEUTICALS, 2024, 17 (06)
  • [7] Ubiquitin-proteasome system and Parkinson's disease
    Olanow, C. Warren
    McNaught, Kevin St. P.
    MOVEMENT DISORDERS, 2006, 21 (11) : 1806 - 1823
  • [8] Tyrosine hydroxylase deficiency associated with dopa-responsive dystonia in a Bulgarian family
    Atanasoska, Maya
    Vazharova, Radoslava
    Balabanski, Lubomir
    Yaneva-Staykova, Slavyana
    Toncheva, Draga
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 303 - 303
  • [9] Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
    Furukawa, Y
    Nygaard, TG
    Gütlich, M
    Rajput, AH
    Pifl, C
    DiStefano, L
    Chang, LJ
    Price, K
    Shimadzu, M
    Hornykiewicz, O
    Haycock, JW
    Kish, SJ
    NEUROLOGY, 1999, 53 (05) : 1032 - 1041
  • [10] PRKN Positive Parkinson's Disease Masked as Dopa-Responsive Dystonia
    Chiu, S.
    Elkouzi, A.
    Almeida, L.
    MOVEMENT DISORDERS, 2019, 34 : S330 - S331